EX-99 2 b69281a1exv99.htm INSIGHT NEWSLETTER exv99
 

(GRAPHIC)
THE CHINA FUND, INC. (CHN)
(PHOTO)
The Martin Currie
Shanghai team
IN BRIEF
       
Net asset value per share
US$   41.21  
Market price
US$   32.90  
Premium/(discount)
   (20.17 %)
Fund size
US$  748.1m  
 
Source: State Street Corporation
     
At 29 February 2008   US$ returns
                 
    China Fund NAV     MSCI Golden Dragon*  
    %     %  
One month
    8.4       8.4  
Year to date
    (7.9 )     (8.8 )
One year
    54.7       29.5  
Three years %pa
    37.1       23.9  
 
  Past performance is not a guide to future returns.
  Source: State Street Corporation. NAV-NAV performance.
* Source for index data: MSCI.
MANAGER’S COMMENTARY
Martin Currie acts as portfolio manager of The China Fund, Inc. (“Fund”). This commentary is the opinion of Martin Currie Inc.
Treading a path between fashionable gloom and the Panglossian optimism of the more enthusiastic Chinese brokers, the Fund had a good month — in net asset value terms, at least. (The share price failed to match the rally in our asset value so the discount is nearing historic lows.) The gains came mainly from the Fund’s positions in stocks oriented towards Taiwanese domestic consumption; a couple of oversold small-caps in Hong Kong also rebounded.
In Beijing, the National People’s Congress will next week confirm the assignment of ministerial roles and, we hope, end the policy vacuum that has persisted since the announcement of the new politburo last October. There will also be some tough talking on inflation, especially as February’s Consumer Price Index number will be poor (January’s was 7.1%). So we probably don’t need to position for a ‘credit-loosening’ relief rally until early April.
The optimists seized on January’s strong export figures (+26.7% year on year) to show that all would be well — an act of gross denial given what is happening in the US, a market that represents half of China’s total trade surplus, not to mention that these figures were flattered by the Chinese New Year effect. Similarly, bank loan growth in January was taken as a sign of credit loosening, when all it showed was the predictable side-effect of imposing loan quotas (if loans are to be rationed, I’ll have mine now, thank you). The A-share market underperformed the Hong Kong market, partly perhaps because China’s local investors interpreted the above figures more accurately, but also because the supply of equity boomed; in addition to large initial public offerings (IPOs), such as China Railway Construction, several large placements were announced (notably by Ping An Insurance and Pudong Development Bank) and the lock-up period for the non-tradable shares of a number of large companies ended. We expect a government response shortly, in the form of a curtailment of IPOs and placements and the granting of more ‘qualified foreign investor’ quota.
The renminbi appreciated by 1.08% against the weakening US dollar in February, in response to inflation and the government’s apparent unwillingness to raise interest rates. The government has got itself into the difficult position of creating a one-way bet for the currency — perhaps another one-off adjustment is the answer? As the year wears on and the impact of the global slowdown is felt, complaints from exporters, already suffering from increased material and labour costs, will rise, closing off this avenue as well.

 


 

INVESTMENT STRATEGY
The Fund is 97.5% invested with holdings in 76 companies. The Fund’s weighting to Taiwan is now 35.6% and to A-shares 11.4%.
Portfolio turnover was light in February. Our main purchase was Qingdao Bright Moon Seaweed, the world’s largest processor of seaweed, the by-products of which are used in a surprisingly wide range of food and pharmaceutical applications. We have bought a 25% stake of this management-owned company for US$6.25 million — a pre-money valuation based on seven times 2008 earnings. The company plans to list on the A-share market within three years.
Our other purchase was Huiyuan Juice, the leader in China’s fast-growing high-quality fruit-juice market. The stock had been sold down on fears of a margin squeeze from the inflation in packaging and raw-material costs. But our investigations showed that margins have stabilised, as increased costs are offset by more local sourcing of fruit and packaging, as well as a price rise.
Chris Ruffle, Martin Currie Inc*
 
*Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to the range of China investment products managed by Martin Currie.
MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of Martin Currie’s China investment products.
HCML has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.

 


 

29 FEBRUARY 2008
FUND DETAILS
     
Market cap   US$597.26m
Shares outstanding   18,153,741
Exchange listed   NYSE
Listing date   July 10, 1992
Investment adviser   Martin Currie Inc
 
Source: State Street Corporation.
SECTOR ALLOCATION
                 
    The China     MSCI Golden  
    Fund, Inc     Dragon  
Consumer discretionary
    19.0 %     5.3 %
Industrials
    16.7 %     10.4 %
Financials
    14.8 %     31.4 %
Consumer staples
    11.3 %     1.4 %
Energy
    10.5 %     9.4 %
Healthcare
    8.8 %      
Materials
    6.5 %     7.8 %
Information technology
    6.4 %     19.5 %
Utilities
    2.3 %     3.6 %
Telecommunications
    1.2 %     11.3 %
Other assets & liabilities
    2.5 %      
Total
    100.0 %     100.0 %
 
Source: State Street Corporation. Source for index data: MSCI
ASSET ALLOCATION
(PIE CHART)
 
Source: State Street Corporation
     
PERFORMANCE   (US$ RETURNS)
                 
    NAV     Market price  
    %     %  
One month
    8.4       2.1  
Year to date
    (7.9 )     (13.5 )
Three years %pa
    37.1       18.4  
 
Past performance is not a guide to future returns.
Source: State Street Corporation
DIRECT INVESTMENTS (3.5%)
             
Qingdao Bright Moon
  Industrials     0.9 %
China Silicon
  Information technology     0.9 %
Highlight Tech
  Industrials     0.8 %
Wuxi Paiho
  Industrials     0.5 %
Sino-Twinwood
  Information technology     0.4 %
teco Optronics
  Information technology      
15 LARGEST LISTED INVESTMENTS (37.0%)
             
Far Eastern Department Stores
  Consumer discretionary     4.4 %
Yunata Financial
  Financials     3.2 %
Chaoda Modern Agriculture
  Consumer staples     3.1 %
Uni-President Enterprises
  Consumer staples     2.8 %
Daqin Railway
  Industrials     2.6 %
China Shenhua Energy
  Energy     2.4 %
Xinao Gas
  Utilities     2.3 %
Synnex Technology
  Consumer discretionary     2.2 %
China Petroleum & Chemical
  Energy     2.2 %
China Metal Products
  Materials     2.1 %
China Development Financial
  Financials     2.0 %
Cathay Financial
  Financials     2.0 %
Zijin Mining
  Materials     1.9 %
China Oilfield Services
  Energy     1.9 %
Fubon Financial Holdings
  Financials     1.9 %
 
Source: State Street Corporation
FUND PERFORMANCE (BASED ON NET ASSET VALUE)
(US$ RETURNS)
                                                         
    One     Three     Calendar     One     Three     Five     Since  
    month     months     year to date     year     years     years     launch  
    %     %     %     %     % pa     % pa     % pa  
The China Fund, Inc.
    8.4       0.4       (7.9 )     54.7       37.1       36.3       13.8  
MSCI Golden Dragon
    8.4       (10.9 )     (8.8 )     29.5       23.9       27.0       n/a  
Hang Seng Chinese Enterprise
    11.8       (18.9 )     (13.4 )     50.7       39.4       44.8       n/a  
Shanghai Stock Exchange 180
    1.7       (0.6 )     (12.1 )     92.2       69.9       33.7       n/a  
 
Past performance is not a guide to future returns.
Source: State Street Corporation. Launch date 10 July 1992. Three year, five year and since launch returns are all annualised.
Source for index data: MSCI for the MSCI Golden Dragon and Copyright 2008 Bloomberg LP for the Hang Seng Chinese Enterprise and the Shanghai Stock Exchange 180. For a full description of each index please see the index descriptions section.

 


 

PERFORMANCE IN PERSPECTIVE
(LINE GRAPH)
 
Past performance is not a guide to future returns.
Source: Martin Currie Inc as at 29 February 2008.
THE CHINA FUND INC. PREMIUM/DISCOUNT
(LINE GRAPH)
 
Past performance is not a guide to future returns.
Source: Martin Currie Inc as at 29 February 2008.
10 YEAR DIVIDEND HISTORY CHART
(LINE GRAPH)
                                                                                                                   
 
  Total     0.50       0.08       0.11       0.00       0.13       0.21       1.78       3.58       2.51       4.01       12.12    
 
Income
      0.50         0.08         0.11         0.00         0.13         0.06         0.07         0.20         0.22         0.30         0.28    
 
Long-term capital
      0.00         0.00         0.00         0.00         0.00         0.00         0.67         3.27         2.29         2.73         9.00    
 
Short-term capital
      0.00         0.00         0.00         0.00         0.00         0.15         1.04         0.11         0.00         0.98         2.84    
 
Past performance is not a guide to future returns.
Source: State Street Corporation.

 


 

29 FEBRUARY 2008
                                         
Sector   Company (BBG ticker)   Price   Holding     Value $     % of portfolio  
Hong Kong
                                    20.0 %
Chaoda Modern Agriculture
  682 HK   HK $ 8.9     20,633,998       23,415,481       3.1 %
Xinao Gas
  2688 HK   HK $ 14.5     9,286,000       17,256,630       2.3 %
Golden Meditech
  8180 HK   HK $ 2.8     35,040,000       12,834,175       1.7 %
Shangri-La Asia
  0069 HK   HK $ 24.1     4,141,555       12,508,070       1.7 %
Huabao International
  336 HK   HK $ 6.7     12,790,000       11,012,967       1.5 %
Natural Beauty Bio-Technology
  157 HK   HK $ 2.1     32,780,000       8,931,077       1.2 %
Ports Design
  589 HK   HK $ 23.4     2,678,500       8,055,018       1.1 %
Intime Department Store Group
  1833 HK   HK $ 7.0     8,778,000       7,885,546       1.0 %
Tianjin Development
  0882 HK   HK $ 7.2     8,440,000       7,777,153       1.0 %
TPV Technology
  903 HK   HK $ 4.7     12,728,000       7,737,137       1.0 %
China Shineway Pharmaceutical
  2877 HK   HK $ 5.1     11,184,000       7,201,018       1.0 %
China Travel International
  0308 HK   HK $ 4.3     10,982,000       6,068,885       0.8 %
SPG Land
  1688 HK   HK $ 4.6     9,868,000       5,782,997       0.8 %
Yorkey Optical International
  2788 HK   HK $ 1.7     16,374,000       3,514,230       0.5 %
China Rare Earth
  769 HK   HK $ 1.8     15,254,000       3,450,289       0.5 %
Chinasoft International
  8216 HK   HK $ 1.3     19,230,000       3,262,212       0.4 %
Fountain Set
  420 HK   HK $ 1.6     10,706,000       2,173,919       0.3 %
Ocean Grand Chemicals
  2882 HK   HK $ 0.3     17,379,000       692,381       0.1 %
Arcontech
  8097 HK           18,386,000              
 
                                       
China ‘B’ shares
                                    1.5 %
Shanghai Lujiazui Finance
  900932 SHA   US $ 2.2     5,130,689       11,282,385       1.5 %
 
                                       
Singapore
                                    4.5 %
China Hongxing Sports
  CHHS SP   SG $ 0.7     19,093,000       9,042,647       1.2 %
China Fishery Group
  CFG SP   SG $ 1.7     6,068,000       7,489,477       1.0 %
Yangzijiang Shipbuilding
  YZJ SP   SG $ 1.1     9,546,000       7,398,141       1.0 %
Hsu Fu Chi International
  HFCI SP   SG $ 1.0     8,409,000       5,853,202       0.8 %
CDW
  CDW SP   SG $ 0.1     60,000,000       3,659,718       0.5 %
 
                                       
Hong Kong ‘H’ shares
                                    15.2 %
China Shenhua Energy
  1088 HK   HK $ 40.8     3,435,000       18,011,335       2.4 %
China Petroleum & Chemical
  386 HK   HK $ 8.9     14,120,000       16,005,243       2.2 %
Zijin Mining
  2899 HK   HK $ 10.7     10,408,000       14,339,073       1.9 %
China Oilfield Services
  2883 HK   HK $ 15.6     7,132,000       14,261,984       1.9 %
Wumart Stores
  995 HK   HK $ 6.2     15,126,000       12,052,435       1.6 %
ZTE Corp
  763 HK   HK $ 43.2     1,597,400       8,827,569       1.2 %
China Railway Group
  390 HK   HK $ 9.3     7,302,000       8,755,531       1.2 %
Shandong Weigao Group
  8199 HK   HK $ 12.1     5,628,000       8,751,822       1.2 %
Zhejiang Expressway
  576 HK   HK $ 7.8     8,664,000       8,707,314       1.1 %
China Huiyuan Juice
  1886 HK   HK $ 6.4     4,877,500       3,980,430       0.5 %
 
                                       
Taiwan
                                    35.6 %
Far Eastern Department Stores
  2903 TT   NT $ 58.0     17,630,080       33,076,003       4.4 %
Yuanta Financial
  2885 TT   HK $ 28.1     26,413,545       24,008,430       3.2 %
Uni-President Enterprises
  1216 TT   NT $ 45.7     14,137,220       20,898,300       2.8 %
Synnex Technology
  2347 TT   NT $ 78.2     6,536,050       16,533,046       2.2 %
China Metal Products
  1532 TT   NT $ 56.9     8,392,675       15,446,974       2.1 %
China Development Financial
  2883 TT   NT $ 12.9     36,871,940       15,385,671       2.0 %
Cathay Financial
  2882 TT   NT $ 80.0     5,708,370       14,771,781       2.0 %
Fubon Financial
  2881 TT   NT $ 34.7     12,603,000       14,125,633       1.9 %
Powertech Technology
  6239 TT   NT $ 106.5     3,581,100       12,336,637       1.6 %
Lien Hwa Industrial
  1229 TT   NT $ 23.5     15,161,855       11,525,266       1.5 %
Tripod Technology
  3044 TT   NT $ 108.0     3,163,083       11,050,072       1.5 %
Ruentex Development
  9945 TT   NT $ 34.1     9,477,000       10,438,035       1.4 %
Merry Electronics
  2439 TT   NT $ 78.9     3,584,340       9,147,806       1.2 %
Taiwan Secom
  9917 TT   NT $ 53.7     4,378,000       8,230,005       1.1 %
HannStar Display
  6116 TT   NT $ 13.7     17,900,000       7,903,445       1.1 %
Wah Lee Industrial
  3010 TT   NT $ 59.2     3,998,856       7,657,521       1.0 %
Formosa Petrochemical
  6505 TT   NT $ 87.0     2,658,000       7,480,058       1.0 %
China Synthetic Rubber
  2104 TT   NT $ 41.2     5,294,000       7,055,242       1.0 %
FamilyMart
  5903 TT   NT $ 55.0     3,557,652       6,329,318       0.9 %
Efun Technology
  3523 TT   NT $ 120.0     1,303,100       5,058,127       0.7 %
Yieh United Steel
  9957 TT   NT $ 12.9     11,379,600       4,748,402       0.6 %
Wintek Corp
  2384 TT   NT $ 31.3     3,148,000       3,187,204       0.4 %
 
                                       
United Kingdom
                                    1.2 %
China Medical System Holdings
  CMSH LN     £ 1.2     3,623,188       8,958,811       1.2 %
 
                                       
United States
                                    4.6 %
Mindray Medical International
  MR US   US $ 36.7     367,000       13,468,900       1.8 %
Far East Energy
  FEEC US   US $ 0.7     11,111,111       8,111,111       1.1 %
The9
  CMED US   HK $ 21.5     356,200       7,665,424       1.0 %
WuXi PharmaTech Cayman
  WX US   HK $ 24.0     230,689       5,536,536       0.7 %

 


 

                                         
Sector   Company (BBG ticker)   Price   Holding     Value $     % of portfolio  
Sector   Company (BBG ticker)     Price     Holding     Value $     % of portfolio  
Equity linked securities (‘A’ shares)
                                    11.4 %
Daqin Railway
          US $ 2.8     6,907,000       19,160,018       2.6 %
Shanghai Zhenhua Port Machinery
          US $ 2.9     4,462,752       12,857,188       1.7 %
Qinghai Salt Lake Potash
          US $ 12.6     887,909       11,153,025       1.5 %
China Yangtze Power
          US $ 2.4     4,169,077       10,214,239       1.4 %
Shanghai Tunnel Engineering
          US $ 2.2     4,439,247       9,966,110       1.3 %
Shanghai International Airport
          US $ 4.5     1,816,700       8,140,633       1.1 %
Finance Street
          US $ 3.2     2,382,259       7,704,225       1.0 %
Shanghai International Port
          US $ 1.1     5,499,923       6,258,912       0.8 %
 
                                       
Direct
                                    3.5 %
Qingdao Bright Moon
          US $ 0.2     31,827,172       7,001,978       0.9 %
China Silicon
          US $ 238.0     27,418       6,525,484       0.9 %
Highlight Tech
          US $ 1.8     3,366,893       5,999,999       0.8 %
Wuxi Paiho
          US $ 4.2     876,190       3,679,998       0.5 %
Sino-Twinwood
          US $ 6.1     500,000       3,050,000       0.4 %
teco Optronics
                  1,861,710              
 
                                       
Other assets & liabilities
                            18,258,701       2.5 %
INDEX DESCRIPTIONS
MSCI Golden Dragon Index
The MSCI Golden Dragon is a free float-adjusted market capitalisation index that is designed to measure equity market performance in the China region. As of May 2005 the MSCI Golden Dragon Index consisted of the following country indices: China, Hong Kong and Taiwan.
Hang Seng China Enterprise Index
The Hang Seng China Enterprise Index is a capitalisation-weighted index comprised of state-owned Chinese companies (H-shares) listed on the Hong Kong Stock Exchange and included in HSMLCI index.
Shanghai Stock Exchange 180 Index
The Shanghai Stock Exchange 180 ‘A’ Share Index is a capitalisation-weighted index. The index tracks the daily price performance of the 180 most representative ‘A’ share stocks listed on the Shanghai Stock Exchange.
OBJECTIVE
The investment objective of the Fund is to achieve long term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in China or which derive a significant part of their revenue from China.
The Board of Directors of the Fund has adopted an operating policy of the Fund, effective 30 June 2001, that the Fund will invest at least 80% of its assets in China companies. For this purpose, “China companies” are (i) companies for which the principal securities trading market is in China; (ii) companies for which the principal securities trading market is outside of China or in companies organised outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have a least 50% of their assets in China; or (iii) companies organised in China. Under the policy, China will mean the People’s Republic of China, including Hong Kong, and Taiwan. The Fund will provide its stockholders with at least 60 days’ prior notice of any change to the policy described above.
The fundamental policy, which applies to not less than 65% of the Fund’s assets as set out in the Fund’s prospectus dated 27 June 2005, remains in place. The fundamental policy is the same as the operating policy set out above, except that China only includes the People’s Republic of China and Hong Kong.
The Fund is subject to the Investment Company Act of 1940 which limits the means in which it can access the ‘A’ share market. The Fund will continue to seek the most efficient way in which to increase its ‘A’ share exposure ensuring ongoing compliance with its legal and regulatory obligations.
CONTACTS
The China Fund, Inc.
c/o State Street Bank and Trust Company
2 Avenue de Lafayette, 6th Floor
PO Box 5049
Boston, MA 02206-5049
Tel: (1) 888 CHN-CALL (246 2255)
www.chinafundinc.com

 


 

Important information: This document is issued and approved by Martin Currie Inc (MC Inc), as investment adviser of the China Fund Inc (the Fund). MC Inc is authorised and regulated by the Financial Services Authority (FSA) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from the newsletter.
Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to our China product. MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of our China funds. HMCL has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.
The Fund is classified as a ‘non-diversified’ investment company under the US Investment Company Act of 1940. It meets the criteria of a closed ended US mutual fund and its shares are listed on the New York Stock Exchange. MC Inc has been appointed investment adviser to the Fund.
Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FSA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FSA’s Conduct of Business Sourcebook of the United Kingdom.
This newsletter does not constitute an offer of shares. MC Inc, its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.
The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased.
It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.
Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:
è   The companies quoted on Greater Chinese stock exchanges are exposed to the risks of political, social and religious instability, expropriation of assets or nationalisation, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation, which may affect income and the value of investments.
 
è   At present, the securities market and the regulatory framework for the securities industry in China is at an early stage of development. The CSRC is responsible for supervising the national securities markets and producing relevant regulations. The Investment Regulations, under which the Fund invests in the People’s Republic of China (‘PRC’) and which regulate repatriation and currency conversion, are new. The Investment Regulations give CSRC and SAFE wide discretions and there is no precedent or certainty as to how these discretions might be exercised, either now or in the future. The Fund may, from time to time, obtain access to the securities markets in China via Access Products. Such products carry additional risk and may be less liquid than the underlying securities which they represent.
 
è   During the past 15 years, the PRC government has been reforming the economic and political systems of the PRC, and these reforms are expected to continue, as evidenced by the recently announced changes. The fund’s operations and financial results could be adversely affected by adjustments in the PRC’s state plans, political, economic and social conditions, changes in the policies of the PRC government such as changes in laws and regulations (or the interpretation thereof), measures which may be introduced to control inflation, changes in the rate or method of taxation, imposition of additional restrictions on currency conversion and the imposition of additional import restrictions.
 
è   PRC’s disclosure and regulatory standards are in many respects less stringent than standards in certain OECD countries, and there may be less publicly available or less reliable information about PRC companies than is regularly published by or about companies from OECD countries.
 
è   The Shanghai Stock Exchange and Shenzhen Stock Exchange have lower trading volumes than most OECD exchanges and the market capitalisations of listed companies are small compared to those on more developed exchanges in developed markets. The listed equity securities of many companies in the PRC are accordingly materially less liquid, subject to greater dealing spreads and experience materially greater volatility than those of OECD countries. These factors could negatively affect the Fund’s NAV.
 
è   The Fund invests primarily in securities denominated in other currencies but its NAV will be quoted in US dollars. Accordingly, a change in the value of such securities against US dollars will result in a corresponding change in the US dollar NAV.
 
è   The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be underdeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.
 
è   The value of the fund’s investment in any Quota will be affected by taxation levied against the relevant QFIIs or in respect of investments held in the relevant Quotas. The PRC taxation regime that will apply to QFIIs and investments made in or through QFII quotas is not clear. The Investment Regulations are new and do not currently expressly contemplate the treatment of QFIIs and investment made through QFII Quotas.
 
è   It should be noted that the position with regard to PRC taxation of the Company and its gains and profits remains unclear. Until such time as the PRC taxation position of the Company is clarified, the Company will process all subscription and redemption requests based upon provisional Net Asset Value calculations, determined without making any provision for PRC capital gains taxation, but with a provision for withholding tax of 10% on all dividend income received. The number of Ordinary shares allotted to any investor, and the final redemption price per share, will be recalculated upon the taxation position being clarified. The Company will require an indemnity in respect of such amount of any redemption proceeds as they consider prudent to allow for potential PRC taxation liabilities that may be included in the final Net Asset Value calculation.
 
    In practice this means that, should any tax be payable retrospectively, the Company’s Net Asset Value will be adjusted to the extent that existing shareholders are liable. All shareholders will be required to sign an indemnity prior to being permitted to redeem all or part of their shareholding to protect the Company and the existing shareholders. Any change to the withholding tax rate which is applied to the Company on an retrospective basis will result in an adjustment of the Net Asset Value of the Company for the benefit of, or if charged at a higher rate than the existing provision, detriment of existing shareholders.
Although Martin Currie complies with the Global Investment Performance Standards (GIPS), the fund returns used in this document are calculated on the net asset value and therefore fall outside the scope of the GIPS standards.
Martin Currie Inc, registered in Scotland (no BR2575)
Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH11 2ES Tel: (44) 131 229 5252 Fax: (44) 131 228 5959 www.martincurrie.com/china
North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY 10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919
Authorised and registered by the Financial Services Authority and incorporated with limited liability in New York, USA.
Please note: calls to the above numbers may be recorded.